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E.  Becher 1,∗,  P.García  Marchiñena  ,  J.  Jaunarena  ,  D.  Santillán  ,
L.  Pérez  ,  B.  Boietti  ,  A.  Jurado  ,  G.  Gueglio
Hospital  Italiano  de  Buenos  Aires,  Argentina










Kidney cancer on the
elderly
Abstract
Objectives:  To compare preoperative Charlson comorbidity Index (CCI) and postoperative complications
after oncologic kidney surgery in patients aged 70 or older. To compare CCI and need for interdisciplinary
evaluation, consults to the emergency department and need of readmission are secondary objectives.
Patients and  methods:  This is a retrospective cohort study. Patients aged 70 or older who underwent partial
or radical nephrectomy were collected from an institutional database. Period: February 2012–June 2014.
Association between CCI and complications was estimated using Chi2.
Results:  Final population: 143 (male: 65%). Age median was 75. Minor postoperative complications were
33.88% (n = 41) for patients CCI ≤  4 versus 9.09% (n = 2) for patients CCI > 4 (p > 0.05), and major postop-
erative complications were 9.91% (n = 12) versus 45.45% (n = 10), respectively (p < 0.01). Interdisciplinary
evaluation was required for 30.6% (n = 37) of patients CCI ≤  4 versus 59% (n = 13) of patients CCI > 4
(p = 0.01). Readmission was needed for 9.09% (n = 11) and 40.1% (n = 11) respectively (p < 0.01).
Conclusions:  Patients with high comorbidity presented more major postoperative complications. These
patients also required more interdisciplinary evaluation after surgery. A higher CCI was not associated withcy de
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he incidence of kidney cancer is growing worldwide [1,2]. It
ccounts for 2% of all cancers diagnosed yearly, and it comprises
ne of the most lethal cancers in urology, with a 35% 5-year cancer
pecific mortality [1].
artial or radical nephrectomy (either laparoscopic or open) are the
tandard of care for clinically localized kidney cancer. Even though
hese procedures have a relatively low risk for complications, that
isk increases if the patient is older, or has a larger comorbidity
urden [3–5].
here are numerous validated scores and models to analyze objec-
ively the patient’s comorbidities. The Charlson Comorbidity Index
CCI) is a robust and strongly validated tool for stratifying subjects
ccording to their comorbidities [6,7].
he CCI was originally developed to serve as a simple, readily appli-
able and valid method of estimating risk of death from comorbid
isease, for use in longitudinal studies [6]. It is also useful as a
redictive tool for postoperative complications in several surgical
cenarios [8–10].
here are numerous articles associating CCI with complications
fter other oncologic or non-oncologic procedures [11]. Neverthe-
ess, the association between CCI and complications after surgery
or renal cancer has not yet been established.
ur primary objectives were to compare preoperative CCI and
resence of postoperative complications after partial or radical
ephrectomy in patients over 70 years old.
econdary objectives were to compare CCI and the need for interdis-
iplinary evaluation, consults to the emergency department and/or
eed of readmission.
atients  and  methods
tudy  design
his is a retrospective cohort study.
atient  populationhe study included patients aged 70 years or older who underwent
artial or radical nephrectomy at our institution between February




Table  1  Grading system of the CCI.
Chronic disease Grade Chronic disease 
Cerebrovascular disease 1 Myocardial infarction 
Congestive heart failure 1 Peripheral Vascular disease 
COPD/asthma 1 Rheumatic disease 
Dementia 1 Ulcer disease 
Depression 1 Hemiplegia 
Diabetes without end organ 1 Moderate/severe renal disea
Hypertension 1 Diabetes with end organ dam
Mild liver disease 1 Any tumor E. Becher et al.
o be malignant. All patients were identified using the institutional,
rospectively collected database.
atients were excluded if they underwent additional surgical proce-
ures simultaneously or had less than 3 months of follow-up.
efinition  of  variables
ge; sex; type of nephrectomy (partial/radical); and technique
open/laparoscopic) were obtained from the database. Comorbid
onditions prior to surgery were queried retrospectively using pre-
perative clinical records. Complications; consults to the emergency
epartment; readmissions; and need for interdisciplinary evaluation
ere assessed retrospectively from electronic clinical records.
he CCI was assessed using the definition by Charlson et al. [12],
here different grades are assigned for specific conditions and the
rades are added to find the index for a specific patient (Table 1).
ostoperative evolution was evaluated studying postoperative com-
lications, need for interdisciplinary evaluation, readmission, or
onsult to the emergency department.
ostoperative complications were assessed using the Dindo-Clavien
DC) classification. All complications that occurred within the first
 months after the intervention were included.
nterdisciplinary evaluation was defined as the need for a clinical
valuation by other specialties (i.e: internal medicine, nephrology,
ardiology) due to postoperative events. Cases which had stipulated
valuation by another specialty previous to the intervention were
ot considered.
atients categorized as ‘need for readmission’ or ‘need for consult
t the emergency department’ were included if the event occurred
ithin the first 3 months after the intervention.
utcome  definition
ur primary outcome was presence of postoperative complications.
econdary outcomes were need for interdisciplinary evaluation;
eed for readmission, and need for consult at the emergency depart-
ent.tatistical  analysis
atients were divided into two groups according to their CCI.
atients were categorized as ‘low comorbidity’ if they had a CCI of
Grade Chronic disease Grade
1 Skin ulcers/cellulitis 2
1 Takes warfarin 1
1 Leukemia 2
1 Lymphoma 2
2 Moderate/severe liver disease 3
se 2 Metastatic solid tumor 6
age 2 HIV/AIDS 6
2
Comorbidities on nephrectomy outcomes 
Table  2  Baseline patient characteristics. Small renal mass (SMR).
Low CCI High CCI p Value
Total 121 22 p > 0.05
Age median 79 72 p > 0.05
Male 65% 63% p > 0.05
Surgical approach
• Open 38 8 p > 0.05
• Laparoscopic 83 14 p > 0.05
Type of surgery
• Radical 67 12 p > 0.05

































has an inherent limitation, the fact that it does not include manyPatients with SMR 65% 52% p = .5
4 or less, and as ‘high comorbidity’ if they had a CCI of more than
4. The CCI was estimated prospectively during the preoperatory
evaluation.
It is important to state that as the CCI gives a score of 2 to patients
having any kind of localized non-skin malignancy, and that all the
patients in the study underwent the procedure due to malignant renal
masses, there were no patients with a CCI lower than 2.
Association between CCI and presence of postoperative complica-
tions; need for readmission; need for interdisciplinary evaluation;
and need for consult to the emergency department was estimated by
Chi square test. A p value of less than 0.05 was considered to be
statistically significant.
Results
The study population was 170 patients. A total of 16 patients
underwent simultaneous procedures along the nephrectomy,
thus they were excluded. Those procedures included: Renal
vein thrombectomy (n = 4), ureterectomy (n = 2), cholecystectomy
(n = 2), gastrectomy (n = 2), urethrectomy (n = 1), aortic aneurism
surgery (n = 1), colectomy (n = 1), spleno-pancreatectomy (n = 1),
resection of metastases in the fibula (n = 1), bank surgery and auto-





Figure  1  Flow of pat389
ne additional patient was excluded because the nephrectomy could
ot be completed due to the local extent of the tumor. A total of 143
atients were finally included in the study (Fig. 1).
aseline patient characteristics are shown on Table 2. Postoperative
omplications were found in 42.1% (n = 53) of patients in the ‘low
omorbidity’ group, and in 63% (n = 14) of the patients in the ‘high
omorbidity’ group (p < 0.05).
or those patients who presented complications, it was found that
3.88% (n = 41) in the ‘low comorbidity’ group versus 9.09% (n = 2)
n the ‘high comorbidity’ group (p > 0.05) had complications grade
C I–II, and that 9.91% (n = 12) versus 45.45% (n = 10), respec-
ively (p < 0.01; 95% CI 2.17–9.00) presented complications DC
IIa or more.
nterdisciplinary evaluation was required for 30.6% (n = 37) of
atients in the ‘low comorbidity’ group versus 59% (n = 13) in the
high comorbidity’ group (p = .01; 95% CI 1.19–2.91). Readmission
as needed for 9.09% (n = 11) in the ‘low comorbidity’ group versus
0.1% (n = 11) in the ‘high comorbidity’ group (p < 0.01; 95% CI
.00–9.27).
onsults to the emergency department were registered for 23.77%
n = 29) patients in the ‘low comorbidity’ versus 36.36% (n = 8) in
he ‘high comorbidity’ group (p > 0.05). These results are summa-
ized on Table 3.
iscussion
he CCI is a robust and well validated score used to categorize
atients according to their comorbidities. Even though there are
any studies that establish a relation between its score and higher
ostoperative complications in different surgical scenarios [8–10],
ts association with outcomes in surgery for kidney tumours has not
et been established.
he index used in the study was conceived as a tool that would help
uantify the serious illnesses of inpatients. Nonetheless, this scoreonditions that are common in elderly patients (i.e.: coronary artery
isease without myocardial infarction; smoking status; history of
ransient ischemic attacks). Further studies should evaluate the use
ients in the study.
390 E. Becher et al.
Table  3  Postoperative outcomes.
Low CCI High CCI p Value
Total complicationsa 54 (42,1%) 14 (63%) p < 0.05
• Minor 41 (33,88%) 2 (9,09%) p > 0.05
• Major 12 (9,91%) 10 (45,45%) p < 0,01
Need for interdisciplinary evaluation 37 (30,6)% 13 (59%) p = 0,01














































































Consult to the emergency department 29 (23,77
a Final population was n = 143.
f a complementary score that contemplates other conditions. Patel
t al. [13] showed that cardiovascular risk has a significant impact
n overall survival in elderly patients diagnosed with small renal
asses (SRM). Future attempts to evaluate risk of intervention in
lderly patients could include the application of the Framingham
eart Study (FHS) to help stratify said risk.
t has been well established that laparoscopic approach offers less
robabilities of complications than open partial or radical nephrec-
omy [14]. Also, that even though partial nephrectomy has greater
hances of postoperative complications, it leads to better outcomes
n renal function and thus improved quality of life [14,15] in the long
erm. Nevertheless, there are few articles in the literature that asso-
iate a single patient-related variable to postoperative outcomes. A
ecent article by Isharwal et al.[16] compared patients comorbidi-
ies to functional recovery after partial or radical nephrectomy. On
his study the authors used a multivariable linear regression to find
ositive associations of single patient comorbidities (such as obe-
ity, diabetes mellitus, hypertension) to recovery of renal function
fter surgery, which were not found. The authors of this study did
ot use a validated index that has been proved to be a predictor of
dverse events, and they did not assess any other plausible com-
lications after surgery. The present article is novel in that matter,
s it positively associates a widely validated index (the CCI) to a
ide range of postoperative complications, readmission, and need
or interdisciplinary evaluation.
his study shows some limitations, such as the inability to discrimi-
ate between the single impact of each variable of the CCI. Froehner
t al. [17] showed that for patients who underwent radical prosta-
ectomy, congestive heart failure was the single most important
ontributing condition for prediction of survival after this procedure.
he fact that the study was carried out retrospectively in a single
enter, should also be considered a limitation. Nevertheless, the
esults that were achieved in the study, and the low budget needed
o carry it out may serve as a kickstarter to create a new protocol
o prospectively include patients, expand the age inclusion criteria,
nd perhaps add other scores to measure the implication of other
omorbidity burdens using other validated scores (i.e: stratifying
ardiovascular risk via FHS [13] in outcomes for renal oncologic
urgery).
anagement of small renal masses in elderly patients is a relevant
nd controversial issue [18–20]. The focus of the controversy is set
n whether or not these patients benefit from an intervention, and
ow to properly select the patients that do. In this study we demon-
trated that patients with a higher CCI are at higher risk of suffering




8 (36,36%) p > 0.05
he CCI is a useful prognostic indicator of mortality in patients with
RM [21,22]. These studies revealed that patients with a CCI > 4
taking into account the 2 points given by the presence of a solid
ocalized cancer) are at higher risk of dying from other non onco-
ogic causes. We found that using the tumour size as an independent
actor, patients with a CCI > 4 are at higher risk of suffering major
omplications from an intervention on their renal tumour.
e do not believe that this fact should disencourage an intervention
n a patient that could benefit from it (i.e: a patient with a larger
umour), but we propose that the CCI could play an important role
n the decision making, and that it is an important tool that could
elp the patient and the professional understand his/her risks before
aking the decision.
onclusion
atients with a CCI higher than 4 (high comorbidity) presented a sig-
ificantly higher postoperative complications rate and readmissions.
hese patients also required significantly more interdisciplinary
valuation after surgery. A higher CCI was not associated with
urther emergency consults.
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